Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Monkeypox Cases in UK Begin to Plateau

Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Antibody & Protein Engineering

AstraZeneca Suffers Sales Decline for COVID Med Evusheld

A 24 million loss has been reported for the preventative COVID-19 treatment.
Antibody & Protein Engineering

Market Battle for Rare Disease Treatment

Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
Immuno-Oncology

AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development

Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Gene Therapy Development

Abundant Stochastic Off-Target Activity by Base Editors

Can complementary approaches for off-target quantification demonstrate substantial levels in various state-of-the-art editors?
NextGen Therapeutics

Bispecific Antibodies for Solid Tumours

Laura von Schantz, Vice President of Discovery at Alligator Bioscience, leads a discussion on the current and future opportunities of bispecific antibodies for solid tumour treatment.

European Approval for Monkeypox Vaccine

The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
Gene Therapy Development

When to Cut and When to Inhibit? A Low-Throughput, Hands-On Investigation Of CRISPR-Cut and CRISPRi Efficiencies In iPSC And Neural Cells

Gene knockdown – the manual reduction of a particular gene's expression in target cells – entails the modification of cellular development in young cells. CRISPR gene editing techniques enable researchers such as Pia Johansson to induce gene knockdown in target cells.
Gene Therapy Development

Overcoming the Challenges of Precision Genome Editing

Experts from academia and industry discuss the current obstacles and opportunities for genome editing during a roundtable session at Gene Therapy Development & Manufacturing: In-Person.

Discussion Group Announcement

Oxford Global’s next round of Biologics Discussion Groups announced.
3D Cell Culture

Speaker Insights – In Conversation with Pedro-Caetano Pinto

Discover key insights into the application of microphysiological systems for advanced kidney and prostate cancer research.
Antibody & Protein Engineering

Widening the Therapeutic Window: Development of Antibody Drug Conjugates for Solid Tumours

Compared to non-solid tumours, solid tumours are more difficult to treat with conventional therapeutic methods. Antibody drug conjugates – biopharmaceutical drugs designed as a targeted therapy for treating cancer – represent a viable treatment alternative.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery